Endocrine Abstracts

Introduction: The prevalence of left ventricular hypertrophy (LVH) is high among patients with chronic kidney disease (CKD) and associated with a lower cardiac functional status, particularly in patients with diabetes mellitus (DM). The aim of the study was to estimate prevalence of LVH and to define factors influencing to development of LVH in patients with diabetic nephropathy (DN).Methods: patients with type 2 DM were studied - 22 males, 43 females, m...

Introduction: The association between diabetes and adverse cardiovascular outcome may be partially explained by the strong independent association of type 2 diabetes with cardiovascular target organ damage, such as left ventricular hypertrophy (LVH), a well-known predictor of cardiovascular events independent of coronary artery disease. The aim of the present study is to evaluate the relation of LVH to fibrinogen and C-reactive protein (CRP) as markers of inflammation and susc...

Background: Micro and macroangiopathy are two major complications of diabetes. Diabetic retinopathy (DR) and nephropathy (ND) which represented microangiopathy, are present early in type 2 diabetes. Macroangiopathy represented by atherosclerotic process assessed through intima-media thickness (IMT) of carotid artery. Microalbuminuria (MI) predictor of ND is associated with DR in type II diabetic patients and is a reliable marker of DR. The aim was to search for association bet...